Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Takeuchi

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
The Journal of Medical Investigation : JMI|November 5, 2020
Resminostat, a histone deacetylase inhibitor, circumvents tolerance to EGFR inhibitors in EGFR-mutated lung cancer cells with BIM deletion polymorphismSachiko Arai, Shinji Takeuchi, Koji Fukuda, et al.
The Science of the Total Environment|August 13, 2021
An analytical survey of benzotriazole UV stabilizers in plastic products and their endocrine-disrupting potential via human estrogen and androgen receptorsYuuta Sakuragi, Hideshige Takada, Hiroya Sato, et al.
The Journal of Medical Investigation : JMI|September 29, 2017
Phase I study of combined therapy with vorinostat and gefitinib to treat BIM deletion polymorphism-associated resistance in EGFR-mutant lung cancer (VICTROY-J): a study protocolShinji Takeuchi, Kenichi Yoshimura, Tadami Fujiwara, et al.
Internal Medicine (Tokyo, Japan)|June 28, 2021
Mediastinal Malignant Melanoma Markedly Shrinking in Response to NivolumabHiroyuki Sakaguchi, Azusa Tanimoto, Shigeki Sato, et al.
Oxford Medical Case Reports|January 4, 2021
Bronchoesophageal fistula formation after three courses of nivolumab for carcinoma of unknown primary with a subgroup of lung squamous cell carcinomaAkihiro Nishiyama, Hiroyuki Sakaguchi, Naohiro Yanagimura, et al.
Chemosphere|April 2, 2011
Determination of dioxin concentrations in fish and seafood samples using a highly sensitive reporter cell line, DR-EcoScreen cellsHiroyuki Kojima, Shinji Takeuchi, Tomoaki Tsutsumi, et al.
Frontiers in Oncology|July 23, 2024
Challenges in the treatment of <i>BRAF</i> K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinibAkihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi, et al.
Frontiers in Oncology|April 22, 2024
Case report: Navigating treatment pathways for cardiac intimal sarcoma with <i>PDGFRβ</i> N666K mutationAkihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi, et al.
Cancer Research|February 6, 2013
EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibitionTakayuki Nakagawa, Shinji Takeuchi, Tadaaki Yamada, et al.
Internal Medicine (Tokyo, Japan)|September 4, 2024
Effectiveness of Additional Immunosuppressive Drugs for Corticosteroid-refractory Immune Checkpoint Inhibitor-induced Myocarditis: Two Case ReportsHiroyuki Sakaguchi, Shigeki Nanjo, Shigeki Sato, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Medical Investigation : JMI|November 5, 2020
Resminostat, a histone deacetylase inhibitor, circumvents tolerance to EGFR inhibitors in EGFR-mutated lung cancer cells with BIM deletion polymorphismSachiko Arai, Shinji Takeuchi, Koji Fukuda, et al.
The Science of the Total Environment|August 13, 2021
An analytical survey of benzotriazole UV stabilizers in plastic products and their endocrine-disrupting potential via human estrogen and androgen receptorsYuuta Sakuragi, Hideshige Takada, Hiroya Sato, et al.
The Journal of Medical Investigation : JMI|September 29, 2017
Phase I study of combined therapy with vorinostat and gefitinib to treat BIM deletion polymorphism-associated resistance in EGFR-mutant lung cancer (VICTROY-J): a study protocolShinji Takeuchi, Kenichi Yoshimura, Tadami Fujiwara, et al.
Internal Medicine (Tokyo, Japan)|June 28, 2021
Mediastinal Malignant Melanoma Markedly Shrinking in Response to NivolumabHiroyuki Sakaguchi, Azusa Tanimoto, Shigeki Sato, et al.
Oxford Medical Case Reports|January 4, 2021
Bronchoesophageal fistula formation after three courses of nivolumab for carcinoma of unknown primary with a subgroup of lung squamous cell carcinomaAkihiro Nishiyama, Hiroyuki Sakaguchi, Naohiro Yanagimura, et al.
Chemosphere|April 2, 2011
Determination of dioxin concentrations in fish and seafood samples using a highly sensitive reporter cell line, DR-EcoScreen cellsHiroyuki Kojima, Shinji Takeuchi, Tomoaki Tsutsumi, et al.
Frontiers in Oncology|July 23, 2024
Challenges in the treatment of <i>BRAF</i> K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinibAkihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi, et al.
Frontiers in Oncology|April 22, 2024
Case report: Navigating treatment pathways for cardiac intimal sarcoma with <i>PDGFRβ</i> N666K mutationAkihiro Nishiyama, Shigeki Sato, Hiroyuki Sakaguchi, et al.
Cancer Research|February 6, 2013
EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibitionTakayuki Nakagawa, Shinji Takeuchi, Tadaaki Yamada, et al.
Internal Medicine (Tokyo, Japan)|September 4, 2024
Effectiveness of Additional Immunosuppressive Drugs for Corticosteroid-refractory Immune Checkpoint Inhibitor-induced Myocarditis: Two Case ReportsHiroyuki Sakaguchi, Shigeki Nanjo, Shigeki Sato, et al.
Pageof 12